Skip to content

Transparency, Trust, and Transformation

Transparency, Trust, and Transformation

Tiger Trials Logo No Background

Tigerlily Foundation’s Clinical Trial Program
is committed to building TRUST through TRANSPARENCY to TRANSFORM the
future of clinical trials.

We are focused on building trust and transparency between patients and science and stakeholders, eliminating barriers to inclusion, achieving equity, and transforming the future of clinical trials. This work is essential to our mission to create a more equitable future for all people with cancer because we cannot develop truly precise treatments without diverse data gathered from Black, Indigenous, People of Color (BIPOC) trial participants.

trust [ truhst ]
(transitive verb)    
a: to rely on the truthfulness or accuracy of : BELIEVE
b: to place confidence in: rely on 
c: to hope or expect confidently 

  • Trust: To us, TRUST is a verb. It requires action. It requires effort. It requires commitment, accountability, and hard work. We understand that trust must be earned, and one of the ways we are dedicated to doing that is by being transparent about clinical trials, both past and present, along with our plans to shape their future. 
  • Transparency: The process of getting a drug from the lab to the patient’s pharmacy is often long and confusing. We beleive it doesn’t have to be. Our trusted partners include top research professionals, physicians, and other healthcare experts who are committed to working with us to demystify this process. From creating trial summaries using plain language, to showing a day in the life of a researcher, to sharing real stories from real women who have participated in clinical trials, and more; you can count on Tiger Trials to bring you accurate, unbiased information about trials without all the jargon.
  • Transformation: We do this work because we believe in a future that includes true health equity. To do that, we have to transform clinical trial participation. We need representation of all races, ethnicities, genders, and ages included in clinical trials. It isn’t always a matter of willingness to participate, in fact, often times it’s more about not being offered trials or the supportive resources needed to stay in a trial. Years of research about trial participation have shown that we need to make sure we are eliminating the barriers that keep people from being able to participate, so we are stepping up to do that because supporting patients is what we do (and we do it WELL). We have big dreams for the future of healthcare, but we can’t do it without you and the thousands of other people who have decided to participate in a trial.  
thumbnail_APPROVED Splash 12